Detalhe da pesquisa
1.
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
Liver Transpl
; 29(7): 683-697, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029083
2.
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.
Liver Transpl
; 27(5): 684-698, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306254
3.
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Hepatology
; 72(6): 2014-2028, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124453
4.
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium.
Ann Surg
; 271(4): 616-624, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30870180
5.
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Ann Surg
; 266(3): 525-535, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28654545